Carmen Busca

2.8k total citations
38 papers, 271 citations indexed

About

Carmen Busca is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Carmen Busca has authored 38 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 16 papers in Infectious Diseases and 14 papers in Hepatology. Recurrent topics in Carmen Busca's work include Hepatitis C virus research (13 papers), HIV-related health complications and treatments (12 papers) and HIV Research and Treatment (9 papers). Carmen Busca is often cited by papers focused on Hepatitis C virus research (13 papers), HIV-related health complications and treatments (12 papers) and HIV Research and Treatment (9 papers). Carmen Busca collaborates with scholars based in Spain, Hungary and United States. Carmen Busca's co-authors include Ángel Robles‐Marhuenda, Maria Aguilera, José Curbelo, Luz Martı́n-Carbonero, Marisa Montes, Juan González‐García, Rafael Micán, Ignacio Valero, José Ignacio Bernardino and Eulalia Valencia and has published in prestigious journals such as PLoS ONE, Hepatology and Frontiers in Immunology.

In The Last Decade

Carmen Busca

33 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmen Busca Spain 9 113 70 50 48 40 38 271
Maria Foggia Italy 10 113 1.0× 91 1.3× 68 1.4× 34 0.7× 31 0.8× 28 314
Jyotirmoy Pal India 9 75 0.7× 85 1.2× 31 0.6× 15 0.3× 40 1.0× 67 277
Giuseppe Ancona Italy 9 141 1.2× 48 0.7× 52 1.0× 103 2.1× 17 0.4× 20 324
Line Meddeb France 8 174 1.5× 73 1.0× 101 2.0× 42 0.9× 59 1.5× 15 345
Thijs E. van Mens Netherlands 12 94 0.8× 36 0.5× 15 0.3× 75 1.6× 23 0.6× 31 442
Ranjit Mankeshwar India 9 82 0.7× 140 2.0× 15 0.3× 27 0.6× 62 1.6× 21 362
Maurizio D’Abbraccio Italy 7 145 1.3× 48 0.7× 118 2.4× 63 1.3× 37 0.9× 13 260
Ethel Zimberg Chehter Brazil 11 52 0.5× 63 0.9× 39 0.8× 14 0.3× 180 4.5× 41 316
Brian Moyers United States 7 82 0.7× 61 0.9× 187 3.7× 56 1.2× 62 1.6× 10 367
Brandon Imp United States 5 74 0.7× 129 1.8× 68 1.4× 71 1.5× 20 0.5× 10 314

Countries citing papers authored by Carmen Busca

Since Specialization
Citations

This map shows the geographic impact of Carmen Busca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Busca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Busca more than expected).

Fields of papers citing papers by Carmen Busca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Busca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Busca. The network helps show where Carmen Busca may publish in the future.

Co-authorship network of co-authors of Carmen Busca

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Busca. A scholar is included among the top collaborators of Carmen Busca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Busca. Carmen Busca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Micán, Rafael, Rosa de Miguel Buckley, Lucía Serrano‐Luján, et al.. (2025). Three-Year Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide as a Switch Strategy in the Real World. Open Forum Infectious Diseases. 12(3). ofaf087–ofaf087. 1 indexed citations
3.
Montes, Marisa, Carmen Busca, Núria Espinosa, et al.. (2024). Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile. Open Forum Infectious Diseases. 11(4). ofae112–ofae112. 4 indexed citations
4.
Berenguer, Juan, Teresa Aldámiz‐Echevarría, Víctor Hontañón, et al.. (2024). Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis. Hepatology. 81(1). 238–253. 3 indexed citations
5.
Buckley, Rosa de Miguel, Carmen Busca, Rafael Micán, et al.. (2024). Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV. HIV Medicine. 25(6). 684–691.
6.
Busca, Carmen, Ángel Robles‐Marhuenda, Mariana Díaz‐Almirón, et al.. (2023). Prevalence and Temporal Trends of Autoimmune Diseases in People Living with HIV. AIDS Research and Human Retroviruses. 39(3). 130–135. 2 indexed citations
7.
Busca, Carmen, et al.. (2023). Benefits of rilpivirine for liver stiffness in HIV/HCV-coinfected patients. Enfermedades infecciosas y microbiologia clinica (English ed ). 42(2). 74–79. 3 indexed citations
8.
Marcelo, Cristina, Lucía Serrano‐Luján, Carmen Busca, et al.. (2023). Epidemiological characteristic and prognosis changes in chronic hepatitis B in people living with HIV. Enfermedades infecciosas y microbiologia clinica (English ed ). 42(3). 130–134. 1 indexed citations
9.
Díaz‐Almirón, Mariana, Carmen Busca, Rafael Micán, et al.. (2022). Change in metabolic parameters after switching from triple regimens with tenofovir alafenamide to dolutegravir‐based dual therapy. Bi‐lipid study. HIV Medicine. 24(5). 558–567. 2 indexed citations
10.
11.
Busca, Carmen, Matilde Sánchez‐Conde, Eulalia Valencia, et al.. (2022). Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens. Open Forum Infectious Diseases. 9(7). ofac279–ofac279. 9 indexed citations
12.
Villatoro, Jaime Monserrat, Gina Mejía‐Abril, Pablo Zubiaur, et al.. (2022). A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching Analysis. Pharmaceuticals. 15(1). 78–78. 5 indexed citations
13.
Serrano‐Villar, Sergio, María Rosa López‐Huertas, Carlos Galera, et al.. (2022). Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens. Frontiers in Immunology. 13. 848630–848630. 6 indexed citations
14.
Martı́n-Carbonero, Luz, Rosa de Miguel Buckley, Lucía Serrano‐Luján, et al.. (2022). Acute hepatitis B among HIV positive persons: A two-decade review of cases from a Spanish cohort. Enfermedades infecciosas y microbiologia clinica (English ed ). 40(3). 121–124. 1 indexed citations
15.
Busca, Carmen, et al.. (2021). Psoriasis and Liver Damage in HIV-Infected Patients. Cells. 10(5). 1099–1099. 2 indexed citations
16.
Busca, Carmen, et al.. (2021). COVID-19 and Pembrolizumab-Induced Secondary Hemophagocytic Lymphohistiocytosis: a Case Report. SN Comprehensive Clinical Medicine. 3(6). 1412–1415. 2 indexed citations
17.
Busca, Carmen, et al.. (2020). A Hypothesis for the Possible Role of Zinc in the Immunological Pathways Related to COVID-19 Infection. Frontiers in Immunology. 11. 1736–1736. 53 indexed citations
18.
Martı́n-Carbonero, Luz, Javier García‐Samaniego, Carmen Busca, et al.. (2020). Patients with hepatitis C lost to follow-up: ethical-legal aspects and search results. Revista Española de Enfermedades Digestivas. 112(7). 532–537. 5 indexed citations
19.
Robles‐Marhuenda, Ángel, et al.. (2019). Chronic granulomatous disease: Single-center Spanish experience. Clinical Immunology. 211. 108323–108323. 2 indexed citations
20.
Casado, Jesús, et al.. (2013). Relación entre hormona paratiroidea y riesgo cardiovascular en pacientes con insuficiencia de vitamina D. Medicina Clínica. 141(7). 292–294. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Foggia Breakdown of academic impact, for papers by Jyotirmoy Pal Breakdown of academic impact, for papers by Giuseppe Ancona Breakdown of academic impact, for papers by Line Meddeb Breakdown of academic impact, for papers by Thijs E. van Mens Breakdown of academic impact, for papers by Ranjit Mankeshwar Breakdown of academic impact, for papers by Maurizio D’Abbraccio Breakdown of academic impact, for papers by Ethel Zimberg Chehter Breakdown of academic impact, for papers by Brian Moyers Breakdown of academic impact, for papers by Brandon Imp
Rankless by CCL
2026